ROBINSON JAMES GEORGE purchased 32.4% of their position (1.15M shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $1.90M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/6/2022ACC: 0001640334-22-000918
Director
Since Oct 2018
+2.30M
Net shares
Net buyer
$1.90M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
2.30M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.15M
Price / share
$1.65
Trade value
$1.90M
% of position
32.4%
—
3.55M→4.70M
Total
Net shares
+1.15M
Net value
$1.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +1.15M | $1.65 | $1.90M | 32.4% | 3.55M | 4.70M |
| Total | +1.15M | $1.90M | ||||||
Derivative Transactions1
Warrant
Direct
Converts to
Common stock
1.15M shares
Shares
+1.15M
Strike price
2.00
Held after
1.15M
Exercisable
—
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant Direct | Common stock1.15M shares | — | P · Purchase | +1.15M | 2.00 | — | 1.15M |